CASI Pharmaceuticals, Inc. Ordinary Shares

CASI XNAS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

4.3M

Short interest (Feb 13)

0.4%

Net Short (Feb 25 ): 0.6%

Borrow Fee

6.75%

↓ 1.0%

Available Shares

700

↓ 58.0%

Price Chart

Company Overview

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Company Info

Exchange: NASDAQ

CIK: 0001962738

Asset Type: CS

Market Data

Market Cap: $4,263,766

Employees: 233

Status: Active

Short Interest

Current Borrow Fee 6.75%

Range: 6.16% - 6.75%

Available Shares 700

Range: 0 - 100K

Recent Changes

Fee Change: ↓ 6.5%

Available Change: ↓ 50.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime